SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-04-037362
Filing Date
2004-03-09
Accepted
2004-03-09 17:13:48
Documents
2
Period of Report
2004-04-13
Effectiveness Date
2004-03-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 308406
3 GRAPHIC g17160g90y79.jpg GRAPHIC 158006
  Complete submission text file 0001193125-04-037362.txt   468146
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-10824 | Film No.: 04658093
SIC: 2835 In Vitro & In Vivo Diagnostic Substances